Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Paul Mintz currently holds 30,000 shares of Nuo Therapeutics, Inc. (AURX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Paul Mintz has been a net neutral trader of AURX stock. They have purchased $0 and sold $0 worth of shares.
Paul Mintz's most recent insider trade was on Jun 29, 2026, when they sold 30,000 shares at $0.00 per share.
Paul Mintz serves as Executive at Nuo Therapeutics, Inc. (AURX). They have executed 10 insider transactions totaling $0 over their tenure at the company.
Paul Mintz holds the position of Executive at Nuo Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 16 years and currently hold a stake valued at $0.
Paul Mintz has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Paul Mintz was on Aug 1, 2025, when they sold $35.0K worth of AURX shares. This transaction involved 20,115 shares at $1.74 per share.
Paul Mintz currently owns 30,000 shares of Nuo Therapeutics, Inc. (AURX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Paul Mintz's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Paul Mintz has 10 Form 4 filings on record as an insider at Nuo Therapeutics, Inc..
Set alerts for Paul Mintz and 40,000+ other insiders.